Hantavirus

Read the Chapter

Sliding Table of Contents on the left of the screen

Tables

Table 1: Hemorrhagic Fever with Renal Syndrome and Hantavirus Syndrome

Vignettes

Mege JL, Meghari S, Honstettre A, Capo C, Raoult D.  The Two faces of interleukin 10 in human infectious diseases.  Lancet Infectious Diseases 2006:7;557-569.

Review Article:  Adhikari P, Mietzner T.  Cell Mediated Immunity. 2008.

Berger S.  Emergence of Infectious Diseases into the 21st Century, 2008.

Authors

Marcela Ferrés, M.D., MPH and Cecilia Perret, M.D.

Smart Search

Guided PubMed Search on the Hit Page

We recommend this option for therapeutic recommendations

Hantavirus

Select a topic and click onto Submit below:

EPIDEMIOLOGY VIROLOGY  CLINICAL MANIFESTATIONS  LAB  DIAGNOSIS PATHOGENESIS

SUSCEPTIBILITY

In Vitro and In Vivo (Animal) Susceptibility | Synergistic Interactions in vitro

ANTIVIRAL THERAPY

Antiviral Agent(s) of Choice | Alternative Therapy  | Combination Therapy | Dose |      Route of Administration | Duration of Therapy | Endpoints for Monitoring Therapy

ADJUNCTIVE THERAPY

Non-antimicrobial Therapy

PREVENTION

General Preventive Measures | Hospital Infection Control Measures | Prophylaxis

VACCINES

www.antimicrobe.org

[Start Page] [Microbes] [Antimicrobial Agents] [HIV Clinical Manual] [Feedback] [Logout]